1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Anatomic Pathology Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Anatomic Pathology Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Anatomic Pathology Market Regional Analysis
6.2 North America Anatomic Pathology Market Revenue 2021-2031 (US$ Million)
6.3 North America Anatomic Pathology Market Forecast Analysis
7. North America Anatomic Pathology Market Analysis – by Product and Services
7.1 Services
- 7.1.1 Overview
- 7.1.2 Services: North America Anatomic Pathology Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Instruments
- 7.2.1 Overview
- 7.2.2 Instruments: North America Anatomic Pathology Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Consumables
- 7.3.1 Overview
- 7.3.2 Consumables: North America Anatomic Pathology Market – Revenue and Forecast, 2021-2031 (US$ Million)
8. North America Anatomic Pathology Market Analysis – by Application
8.1 Disease Diagnosis
- 8.1.1 Overview
- 8.1.2 Disease Diagnosis: North America Anatomic Pathology Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Drug Discovery and Development
- 8.2.1 Overview
- 8.2.2 Drug Discovery and Development: North America Anatomic Pathology Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Others
- 8.3.1 Overview
- 8.3.2 Others: North America Anatomic Pathology Market – Revenue and Forecast, 2021-2031 (US$ Million)
9. North America Anatomic Pathology Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: North America Anatomic Pathology Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Research Laboratories
- 9.2.1 Overview
- 9.2.2 Research Laboratories: North America Anatomic Pathology Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Diagnostic Laboratories
- 9.3.1 Overview
- 9.3.2 Diagnostic Laboratories: North America Anatomic Pathology Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.4 Others
- 9.4.1 Overview
- 9.4.2 Others: North America Anatomic Pathology Market – Revenue and Forecast, 2021-2031 (US$ Million)
10. North America Anatomic Pathology Market – North America Analysis
10.1 Overview
10.2 North America
- 10.2.1 North America Anatomic Pathology Market Breakdown, by Key
Country, 2024 and 2031 (%)
- 10.2.1.1 North America Anatomic Pathology Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 US:
North America Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.1.1 US: North America Anatomic Pathology Market Breakdown, by Product and Services
- 10.2.1.1.2 US: North America Anatomic Pathology Market Breakdown, by Application
- 10.2.1.1.3 US: North America Anatomic Pathology Market Breakdown, by End User
- 10.2.1.2 Canada:
North America Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.2.1 Canada: North America Anatomic Pathology Market Breakdown, by Product and Services
- 10.2.1.2.2 Canada: North America Anatomic Pathology Market Breakdown, by Application
- 10.2.1.2.3 Canada: North America Anatomic Pathology Market Breakdown, by End User
- 10.2.1.3 Mexico:
North America Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.3.1 Mexico: North America Anatomic Pathology Market Breakdown, by Product and Services
- 10.2.1.3.2 Mexico: North America Anatomic Pathology Market Breakdown, by Application
- 10.2.1.3.3 Mexico: North America Anatomic Pathology Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 F. Hoffmann-La Roche Ltd
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Beckman Coulter Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Hologic Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Agilent Technologies Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 BioGenex Laboratories Inc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Diapath S.p.A.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Bio SB
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Merck KGaA
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 PHC Holdings Corporation
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Get Free Sample For North America Anatomic Pathology Market
